Scott Coleman
Corporate Officer/Principal at XILIO THERAPEUTICS, INC.
Scott Coleman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| XILIO THERAPEUTICS, INC. | Corporate Officer/Principal | 2022-05-31 | - |
Career history of Scott Coleman
Former positions of Scott Coleman
| Companies | Position | Start | End |
|---|---|---|---|
| ACCELERON PHARMA INC. | Corporate Officer/Principal | - | - |
Training of Scott Coleman
| North Carolina State University | Doctorate Degree |
| Northeastern University | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| XILIO THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Scott Coleman
- Experience
